Point-of-care test of heart-type fatty acid-binding protein for the diagnosis of early acute myocardial infarction

Increase in Skin Autofluorescence and Release of Heart-Type Fatty Acid Binding Protein in Plasma Predicts Mortality of Hemodialysis Patients

“…Others demonstrated that H‐FABP is a strong predictor of mortality in patients with cardiovascular disorders: acute pulmonary embolism , chronic pulmonary hypertension , acute coronary syndrome , acute chest pain , and chronic heart failure . H‐FABP is a very sensitive marker of acute myocardial and kidney damage , and is now known also to contribute to a more accurate prediction of the 3‐year survival of HD patients maybe because the HD treatment itself caused myocardial damage .…”

Salivary high‐sensitivity cardiac troponin T levels in patients with acute myocardial infarction

“…Several studies were conducted to compare using POC tests vs central laboratory assays in terms of identifying acute MI and outcome prediction in patients presented with chest pain, with some for and others against the POC (Li et al, 2010;Venge et al, 2010;Goodacre et al, 2011). Efforts on designing and developing more efficient POC assays are still in progress, the main focus being on their reliability, ease of use and rapid performance (Wang et al, 2009).…”

Heart-type fatty acid binding protein as an early marker for myocardial infarction: systematic review and meta-analysis

“…We included eight recent studies that have been published since the other meta-analysis was undertaken12–14 17–19 22 23 and excluded six older studies that used the old WHO definition of MI35–40 and one study where we were unable to extract data 41. Thus, only nine studies15 16 20 21 24–28 were included in both reviews.…”